"Frontline Therapy for Thoracic Malignancies" is an interactive, gamified activity designed to deepen understanding of optimal frontline therapies, including targeted and immunotherapies, for thoracic cancers. Featuring multiple-choice questions with immediate feedback and leaderboard tracking, this activity engages participants in applying evidence-based strategies to select effective first-line treatments.
Course Accreditations
This activity is supported with Independent Medical Education Grants from: Exact Sciences MSD Varian Medical Systems 0.5 AMA PRA Category 1 Credit™ The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission. 0.5 Nursing Contact Hours Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours. 0.5 ABIM MOC II Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Course Summary
| Events Starts | Events Ends |
|---|---|
| 3/12/2025 | 3/12/2025 |
- Medical Oncologists
- Surgeons
- Radiation Oncologists
- Pathologists
- Oncology Fellows
- Oncology Nurses
- Nurse Practitioners
- Physician Assistants
- Pharmacists
Target Audience
- Identify appropriate frontline therapies for different thoracic malignancies.
- Select targeted versus immunotherapy based on patient and tumor-specific factors in thoracic cancers.
- Apply evidence-based guidelines to improve treatment selection and patient outcomes in the frontline management of thoracic malignancies.
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: